- Common side effects include nausea, diarrhea, vomiting, and constipation
Weight loss from GLP-1 therapy may reduce insulin resistance and androgen levels, potentially decreasing sebum production in some individuals
Dai for technical assistance, S
Inhibition of mammalian target of rapamycin or apoptotic pathway induces autophagy and radiosensitizes PTEN null prostate cancer cells
When people lose weight quickly, they often lose fat from their face as well
"We welcome the Medicare GLP-1 Bridge as an important step in getting Wegovy to more patients and will continue to work with CMS, healthcare professionals, pharmacists, and patient advocates to support implementation and help eligible seniors access the care they need and deserve." The Medicare GLP-1 Bridge provides eligible patients access to Wegovy for weight management